Videos

Overview of EGFR Exon 20 and Molecular Testing in NSCLC

April 29th 2022

Experts explain the presence and role of EGFR exon 20 insertion mutations in non–small cell lung cancer and highlight the role of molecular profiling.

Educated Patient® Kidney Cancer Summit IO/TKI Therapies Presentation: April 9, 2022

April 29th 2022

Watch Dr. Jeff Yorio, from Texas Oncology, discuss treatment with the combination of immunotherapy and tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

Educated Patient® Kidney Cancer Summit IO/IO Therapies Presentation: April 9, 2022

April 28th 2022

Watch Dr. Saby George, from Roswell Park Comprehensive Cancer Center, discuss treatment with the combination of immunotherapies, during the CURE Educated Patient Kidney Cancer Summit.

Communicating With Care Providers While on Therapy for DTC

April 28th 2022

Discussion on how best to communicate with care providers while undergoing therapy for iodine-refractory differentiated thyroid cancer.

Radioiodine-Refractory DTC: Dosing Considerations for Lenvatinib Therapy

April 28th 2022

Considerations for how dosing and dose reductions can be used to optimize use of lenvatinib for iodine-refractory DTC.

Educated Patient® Kidney Cancer Summit Panel on Communicating With Providers About Immunotherapy/TKI Combo Treatment: April 9, 2022

April 27th 2022

Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss communicating with a care team about treatment with immunotherapy combined with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

Educated Patient® Kidney Cancer Summit Panel on Side Effects from Immunotherapy/TKI Combo Treatment: April 9, 2022

April 26th 2022

Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss side effects and dose reductions after treatment with immunotherapy combined with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

Educated Patient® Kidney Cancer Summit Panel on Immunotherapy/TKI Combo Treatment: April 9, 2022

April 25th 2022

Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss the treatment of combining immunotherapy with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

Educated Patient® Kidney Cancer Summit Frontline Therapy Panel: April 9, 2022

April 24th 2022

Watch Dr. Thomas Hutson, Dr. Jose Karam, Dr, Naomi Haas, and Kiran Kehoe answer questions about frontline therapy during the CURE Educated Patient Kidney Cancer Summit.

Educated Patient® Kidney Cancer Summit Adjuvant Therapy Options Presentation: April 9, 2022

April 23rd 2022

Watch Dr. Naomi Haas, from Abramson Cancer Center, discuss adjuvant therapy options, during the CURE Educated Patient Kidney Cancer Summit.

Educated Patient® Kidney Cancer Summit Surgical Options Presentation: April 9, 2022

April 22nd 2022

Watch Dr. Jose Karam, from The University of Texas MD Anderson Cancer Center, discuss surgical options, during the CURE Educated Patient Kidney Cancer Summit.

Role of Nurses in the Multidisciplinary Management of RCC

April 21st 2022

Clinical nurse Kiran Virdee explains why a multidisciplinary treatment approach to clear cell renal cell carcinoma is beneficial.

Factors for Consideration in RCC Treatment Decision-Making

April 21st 2022

An oncologist describes the necessity of discussing options with a patient when picking a treatment approach for clear cell renal cell carcinoma.

Receiving Lenvatinib Therapy for Iodine-Refractory DTC

April 21st 2022

Expert and patient perspectives on receiving lenvatinib therapy for iodine-refractory differentiated thyroid cancer.

Educated Patient® Kidney Cancer Summit Diagnosis Panel: April 9, 2022

April 21st 2022

Watch Dr. Vitaly Margulis, Dr. Rana Mckay and Kwame Garrett-Price answer questions about kidney cancer diagnoses during the CURE Educated Patient Kidney Cancer Summit.

Radioiodine-Refractory DTC: An Overview of Work-up and Treatment Options

April 21st 2022

Health care specialists share insight on the work-up of patients with iodine-refractory differentiated thyroid cancer and how this may affect systemic therapy options.

How a Standardized Staging System Helps Patients, Providers Choose Best Kidney Cancer Treatment Options

April 20th 2022

By understanding what a TNM staging score is, patients and clinicians can determine the best line of treatment for their kidney cancer, as well as what the survivorship care plan should be.

Educated Patient® Kidney Cancer Summit Genetic Testing in RCC Presentation: April 9, 2022

April 20th 2022

Watch Dr. Rana R. McKay, from the University of California San Diego, discuss genetic testing in renal cell carcinoma during the CURE Educated Patient Kidney Cancer Summit.

Lenvatinib + Pembrolizumab for the Treatment of Metastatic Clear Cell RCC

April 19th 2022

A review of clinical trial data on combination treatments for clear cell renal cell carcinoma.

A Patient’s Perspective on Choosing Systemic Therapy for Metastatic RCC

April 19th 2022

Patients with clear cell renal cell carcinoma speak to their experiences with systemic treatments.

Educated Patient® Kidney Cancer Summit Staging Presentation: April 9, 2022

April 19th 2022

Watch Dr. Vitaly Margulis, from UT Southwestern Medical Center, discuss staging, during the CURE Educated Patient Kidney Cancer Summit.

Identifying and Monitoring Radioiodine-Refractory DTC

April 14th 2022

Discussion on when differentiated thyroid cancer is determined to be iodine-refractory, and how patients should be followed in this setting.

Radioiodine Therapy for Differentiated Thyroid Cancer Following Surgery

April 14th 2022

Expert perspectives on the process of surgery and radiation therapy used for less severe cases of differentiated thyroid cancer.

Finding Someone You Trust: Cancer Hope Network Advocate Highlights Programs Available for Patients with Lung Cancer

April 11th 2022

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about the importance of support following a lung cancer diagnosis.

Advocate Discusses Emotional Side Effects from Lung Cancer, and the Types of Support Available to Help

April 11th 2022

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about the psychosocial effects of a lung cancer diagnosis.

Caring for the Caregiver: Seeking Support Through Cancer Hope Network

April 11th 2022

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about support for caregivers of patients with lung cancer.

Advocate Discusses Types of Support for End-Stage Cancer Available for Patients and Their Loved Ones

April 11th 2022

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, from Cancer Hope Network, about seeking support for patients who may be nearing end of life, as well as support for family and friends after a loved one has passed.

Educated Patient® Multiple Myeloma Summit New Therapies on the Horizon Panel: March 12, 2022

April 9th 2022

Watch Kristie L. Kahl, with Sham Mailankody, MBBS; Cesar Rodriguez, MD; and Lynn Steele, discuss new therapies on the horizon, during the CURE Educated Patient Multiple Myeloma Summit.

Newfound Sense of Empathy Makes Cancer Survivor ‘Feel More Human’

April 8th 2022

After surviving cancer and the many bad days that come with a diagnosis, voice actor Rob Paulsen noted that he had a newfound sense of empathy that helped him out of some of his darkest days.

First-Line Treatment Options for Metastatic Clear Cell RCC

April 8th 2022

An overview of first-line treatment options for metastatic clear cell renal cell carcinoma.

NEXT PAGE
PREVIOUS PAGE